Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Fermented dairy foods (FDFs) and probiotics are promising tools for the prevention and management of cardiometabolic diseases (CMDs), respectively. The relation between the regular consumption of FDFs and CMD risk factors was assessed by prospective cohort studies (PCSs), and the effect of probiotic supplementation added into a dairy matrix on CMD parameters was evaluated by randomized controlled trials (RCTs). Moreover, the effects of probiotic supplementation added into a dairy matrix were compared with those administered in capsule/powder form. Twenty PCSs and 52 RCTs met the inclusion criteria for the systematic review and meta-analysis. In PCSs, fermented milk was associated with a 4% reduction in risk of stroke, ischemic heart disease, and cardiovascular mortality [RR (95% CI); 0.96 (0.94, 0.98)]; yogurt intake was associated with a risk reduction of 27% [RR (95% CI); 0.73 (0.70, 0.76)] for type 2 diabetes (T2D) and 20% [RR (95% CI); 0.80 (0.74, 0.87)] for metabolic syndrome development. In RCTs, probiotic supplementation added into dairy matrices produced a greater reduction in lipid biomarkers than when added into capsules/powder in hypercholesterolemic subjects, and probiotic supplementation by capsules/powder produced a greater reduction in T2D biomarkers than when added into dairy matrices in diabetic subjects. Both treatments (dairy matrix and capsules/powder) resulted in a significant reduction in anthropometric parameters in obese subjects. In summary, fermented milk consumption is associated with reduced cardiovascular risk, while yogurt intake is associated with a reduced risk of T2D and metabolic syndrome development in the general population. Furthermore, probiotic supplementation added into dairy matrices could be considered beneficial for lowering lipid concentrations and reducing anthropometric parameters. Additionally, probiotic capsule/powder supplementation could contribute to T2D management and reduce anthropometric parameters. However, these results should be interpreted with caution due to the heterogeneity of the studies and the different probiotic strains used in the studies. This trial is registered with PROSPERO (CRD42018091791) and the protocol can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018091791.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Health benefits of fermented foods: Microbiota and beyond
Marco, M. L., Heeney, D., Binda, S., Cifelli, C. J., Cotter, P. D., Foligné, B., Gänzle, M., Kort, R., Pasin, G., Pihlanto, A., et al. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.11.010 · Cited by 1,674
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M., & Tsuchida, T. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.19 · Cited by 700
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012) · Nutrition · doi:10.1016/j.nut.2011.08.013 · Cited by 683
Gijsbers, L., Ding, E. L., Malik, V. S., de Goede, J., Geleijnse, J. M., & Soedamah-Muthu, S. S. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.123216 · Cited by 404 · cited 1×
“Similarly, in another meta-analysis of 2 PCSs, cheese intake was associated with a 5% higher T2D risk (96).”
ResultDairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
Chen, M., Sun, Q., Giovannucci, E., Mozaffarian, D., Manson, J. E., Willett, W. C., & Hu, F. B. (2014) · BMC Medicine · doi:10.1186/s12916-014-0215-1 · Cited by 370
Yogurt and other fermented foods as sources of health-promoting bactéria
Kok, C. R., & Hutkins, R. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy056 · Cited by 317
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281
Borgeraas, H., Johnson, L. K., Skattebu, J., Hertel, J. K., & Hjelmesæth, J. (2018) · Obesity Reviews · doi:10.1111/obr.12626 · Cited by 278
Jones, M. L., Martoni, C. J., & Prakash, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.126 · Cited by 277
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Obesity · doi:10.1002/oby.20585 · Cited by 202 · cited 1×
“Keywords: probiotics, fermented dairy, cardiometabolic disease, obesity, hypercholesterolemia, type 2 diabetes Introduction Cardiometabolic diseases (CMDs) are a group of chronic diseases that include obesity, dyslipidemia, type 2 diabetes (T2D), hypertension, and metabolic syndrome that promote cardiovascular (CV) di…”
BackgroundKim, J., Yun, J. M., Kim, M. K., Kwon, O., & Cho, B. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.3937 · Cited by 182
Sonestedt, E., Wirfält, E., Wallström, P., Gullberg, B., Orho-Melander, M., & Hedblad, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9589-y · Cited by 171
Brahe, L. K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Blædel, T., Håkansson, J., Dalsgaard, T. K., Hansen, T., Pedersen, O., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515001786 · Cited by 171
Ericson, U., Hellstrand, S., Brunkwall, L., Schulz, C.-A., Sonestedt, E., Wallström, P., Gullberg, B., Wirfält, E., & Orho-Melander, M. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103010 · Cited by 171 · cited 34×
“The meta-analysis of 3 PCSs (39–41) that evaluated the relation of yogurt intake with metabolic syndrome risk development resulted in a significant 20% reduction in metabolic syndrome risk development [RR (95% CI); 0.80 (0.74, 0.87)], and the heterogeneity between PCSs was low (P = 0.416, I2 = 0.0%; Figure 2D).”
BackgroundInfluentialDíaz-López, A., Bulló, M., Martínez-González, M. A., Corella, D., Estruch, R., Fitó, M., Gómez-Gracia, E., Fiol, M., García de la Corte, F. J., Ros, E., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-015-0855-8 · Cited by 165 · cited 2×
“The meta-analysis of 3 PCSs (28, 32, 35) that evaluated the relation of cheese intake with T2D risk development resulted in a significant 24% increase in T2D risk development [RR (95% CI); 1.”
BackgroundMethodKey, T. J., Appleby, P. N., Bradbury, K. E., Sweeting, M., Wood, A., Johansson, I., Kühn, T., Steur, M., Weiderpass, E., Wennberg, M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038813 · Cited by 147
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
Madsbad, S. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12119 · Cited by 146
Jung, S.-P., Lee, K.-M., Kang, J.-H., Yun, S.-I., Park, H.-O., Moon, Y., & Kim, J.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.2.80 · Cited by 140
Zarrati, M., Salehi, E., Nourijelyani, K., Mofid, V., Zadeh, M. J. H., Najafi, F., Ghaflati, Z., Bidad, K., Chamari, M., Karimi, M., et al. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.874937 · Cited by 130 · cited 1×
“Importantly, the combination of probiotic intake with a low-calorie diet was a more effective treatment for reducing anthropometric parameters than probiotics or diet alone (47, 49, 57).”
BackgroundSayon-Orea, C., Martínez-González, M. A., Ruiz-Canela, M., & Bes-Rastrollo, M. (2017) · Advances in Nutrition · doi:10.3945/an.115.011536 · Cited by 84 · cited 1×
“In agreement with these results, another systematic review of PCSs, published in 2016, suggested a reduction in the risk of metabolic syndrome development with yogurt consumption (95).”
ResultFuentes, M. C., Lajo, T., Carrión, J. M., & Cuñé, J. (2016) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-160065 · Cited by 31
Cited by
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Probiotics in the dairy industry—Advances and opportunities
Gao, J., Li, X., Zhang, G., Sadiq, F. A., Simal‐Gandara, J., Xiao, J., & Sang, Y. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12755 · Cited by 195
“Probiotic supplementation into dairy matrices is considered to positively regulate lipid concentrations and reduce anthropometric parameters (Companys et al., 2020).”
BackgroundSun, J., Song, J., Yang, J., Chen, L., Wang, Z., Duan, M., Yang, S., Hu, C., & Bi, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.789006 · Cited by 29
“Over the past several decades, many epidemiological pieces of evidence have reported that yogurt consumption is associated with decreased risk of metabolic syndrome (41), hip fracture (42), type 2 diabetes (43), cardiovascular diseases (44), etc.”
BackgroundEffect of yogurt consumption on metabolic syndrome risk factors: A narrative review
Khorraminezhad, L., & Rudkowska, I. (2021) · Current Nutrition Reports · doi:10.1007/s13668-020-00344-y · Cited by 9
Metadata
- Authors
- Companys, J., Pla-Pagà, L., Calderón-Pérez, L., Llauradó, E., Solà, R., Pedret, A., & Valls, R. M.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 11
- Issue
- 4
- Pages
- 834-863
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W3015331944
- Cited by
- 149
- References
- 25
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.